PAX5 and nasopharyngeal carcinoma: Among them, PAX5 has been well established to be involved in B cell development and correlated with Epstein‐Barr virus‐associated NPC,20, 21 and HOXC6 has been demonstrated to be associated with Ki‐67 expression and poor survival in NPC patients.22